DIN 02243559 — SANDOZ ORPHENADRINE 100 MG
SANDOZ ORPHENADRINE is a tablet (extended-release) of Orphenadrine marketed by SANDOZ CANADA INCORPORATED. The full Orphenadrine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02243559
- Brand name
- SANDOZ ORPHENADRINE
- Active ingredient
- Orphenadrine
- Strength
- 100 MG
- Dosage form
- TABLET (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- Centrally acting skeletal muscle relaxant with antimuscarinic (anticholinergic) activity
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Orphenadrine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02047535 | ORFENACE TABLET 100MG | 100 MG | TABLET | STERIMAX INC | DORMANT |
| 02229731 | ORPHENADRINE CITRATE INJECTION, USP | 30 MG | LIQUID | STERIMAX INC | DORMANT |